Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew Muir, Sricharan Gopakumar, Jeffrey Traylor, Sungho Lee & Ganesh Rao. (2020) Glioblastoma multiforme: novel therapeutic targets. Expert Opinion on Therapeutic Targets 24:7, pages 605-614.
Read now
Read now
Jennifer H Kang & Cory Adamson. (2015) Novel chemotherapeutics and other therapies for treating high-grade glioma. Expert Opinion on Investigational Drugs 24:10, pages 1361-1379.
Read now
Read now
Articles from other publishers (19)
Debo Yun, Jianshen Liang, Xuya Wang, Jikang Fan, Xisen Wang, Jiabo Li, Xiao Ren, Jie Liu, Xiude Ren, Hao Zhang, Guanjie Shang, Wenzhe Jin, Lei Chen, Tao Li, Chen Zhang, Shengping Yu & Xuejun Yang. (2023) TCAF2 drives glioma cellular migratory/invasion properties through STAT3 signaling. Molecular and Cellular Biochemistry.
Crossref
Crossref
Wenda Huang, Zhaonian Hao, Feng Mao & Dongsheng Guo. (2022) Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future. Frontiers in Oncology 12.
Crossref
Crossref
Veysel Haksoyler, Ali A Besen, Tolga Koseci, Polat Olgun, Ertugrul Bayram & Erkan Topkan. (2021) Neutrophil-to-lymphocyte ratio is prognostic in recurrent glioblastoma multiforme treated with bevacizumab plus irinotecan. Biomarkers in Medicine 15:11, pages 851-859.
Crossref
Crossref
Gengqiang Ling, Qiao Ji, Wei Ye, Dongying Ma & Yuena Wang. (2016) Epithelial-mesenchymal transition regulated by p38/MAPK signaling pathways participates in vasculogenic mimicry formation in SHG44 cells transfected with TGF-β cDNA loaded lentivirus in vitro and in vivo. International Journal of Oncology 49:6, pages 2387-2398.
Crossref
Crossref
Johannes Notni, Katja Steiger, Frauke Hoffmann, Dominik Reich, Tobias G. Kapp, Florian Rechenmacher, Stefanie Neubauer, Horst Kessler & Hans-Jürgen Wester. (2016)
Complementary, Selective PET Imaging of Integrin Subtypes α
5
β
1
and α
v
β
3
Using
68
Ga-Aquibeprin and
68
Ga-Avebetrin
. Journal of Nuclear Medicine 57:3, pages 460-466.
Crossref
Crossref
Francis S. Markland & Stephen D. Swenson. 2016. Venom Genomics and Proteomics. Venom Genomics and Proteomics
393
424
.
Luigi Battaglia, Marina Gallarate, Elena Peira, Daniela Chirio, Ilaria Solazzi, Susanna Marzia Adele Giordano, Casimiro Luca Gigliotti, Chiara Riganti & Chiara Dianzani. (2015)
Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary
in vitro
studies
. Nanotechnology 26:25, pages 255102.
Crossref
Crossref
Jana Jaal, Marju Kase, Ave Minajeva, Mikk Saretok, Aidi Adamson, Jelizaveta Junninen, Tõnis Metsaots, Tõnu Jõgi, Madis Joonsalu, Markus Vardja & Toomas Asser. (2015) VEGFR-2 Expression in Glioblastoma Multiforme Depends on Inflammatory Tumor Microenvironment. International Journal of Inflammation 2015, pages 1-7.
Crossref
Crossref
Anthony Turpin, Ariane Sharif, Luc Stoven, Serge Blond, Claude-Alain Maurage & Émilie Le Rhun. (2015) La niche des cellules souches tumorales dans le glioblastome : des aspects fondamentaux au ciblage thérapeutique. Bulletin du Cancer 102:1, pages 24-33.
Crossref
Crossref
Darryl Lau, Stephen T. Magill & Manish K. Aghi. (2014) Molecularly targeted therapies for recurrent glioblastoma: current and future targets. Neurosurgical Focus 37:6, pages E15.
Crossref
Crossref
Ryan Grant, Luis Kolb & Jennifer Moliterno. (2014) Molecular and genetic pathways in gliomas: the future of personalized therapeutics. CNS Oncology 3:2, pages 123-136.
Crossref
Crossref
Roland Haubner, Simone Maschauer & Olaf Prante. (2014) PET Radiopharmaceuticals for Imaging Integrin Expression: Tracers in Clinical Studies and Recent Developments. BioMed Research International 2014, pages 1-17.
Crossref
Crossref
Roland Haubner, Simone Maschauer, Jürgen Einsiedel, Iris E. Eder, Christine Rangger, Peter Gmeiner, Irene J. Virgolini & Olaf Prante. (2014)
H-CRRETAWAC-OH, a Lead Structure for the Development of Radiotracer Targeting Integrin
α
5
β
1
?
. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
Francis S. Markland & Stephen D. Swenson. 2021. Toxinology. Toxinology
1
27
.
Thomas Daubon & Andreas Bikfalvi. 2014. Molecular Mechanisms of Angiogenesis. Molecular Mechanisms of Angiogenesis
307
324
.
Sophie Javerzat, Virginie Godard & Andreas Bikfalvi. (2013) Balancing risks and benefits of anti-angiogenic drugs for malignant glioma. Future Neurology 8:2, pages 159-174.
Crossref
Crossref
Luca Persano, Elena Rampazzo, Giuseppe Basso & Giampietro Viola. (2013) Glioblastoma cancer stem cells: Role of the microenvironment and therapeutic targeting. Biochemical Pharmacology 85:5, pages 612-622.
Crossref
Crossref
Michael Weller, Timothy Cloughesy, James R. Perry & Wolfgang Wick. (2013) Standards of care for treatment of recurrent glioblastoma—are we there yet?. Neuro-Oncology 15:1, pages 4-27.
Crossref
Crossref
Karl H. Plate, Alexander Scholz & Daniel J. Dumont. (2012) Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathologica 124:6, pages 763-775.
Crossref
Crossref